BlackRock Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.77M Buy
54,984
+3,435
+7% +$88K ﹤0.01% 2304
2016
Q3
$1.35M Sell
51,549
-101
-0.2% -$2.64K ﹤0.01% 2462
2016
Q2
$1.2M Buy
51,650
+15,294
+42% +$381K ﹤0.01% 2492
2016
Q1
$994K Buy
36,356
+4,727
+15% +$98.9K ﹤0.01% 2495
2015
Q4
$900K Buy
31,629
+2,315
+8% +$62.1K ﹤0.01% 2666
2015
Q3
$512K Buy
29,314
+175
+0.6% +$3.42K ﹤0.01% 3014
2015
Q2
$525K Buy
29,139
+19,077
+190% +$261K ﹤0.01% 3105
2015
Q1
$125K Buy
10,062
+983
+11% +$12.2K ﹤0.01% 3281
2014
Q4
$107K Buy
9,079
+639
+8% +$7.44K ﹤0.01% 3323
2014
Q3
$111K Buy
+8,440
New +$110K ﹤0.01% 3294

Other funds holding LOXO

BlackRock Investment Management's LOXO Position: Q4 2016 in Review

BlackRock Investment Management increased its Loxo Oncology, Inc (LOXO) stake by 6.7% in Q4 2016, buying an estimated $88K and bringing the position to 54,984 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2304.

BlackRock Investment Management first reported a position in LOXO in Q3 2014 and has held it in 10 quarters since. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • BlackRock Investment Management held 54,984 shares of Loxo Oncology, Inc worth $1.77M as of Q4 2016.
  • BlackRock Investment Management bought 3,435 Loxo Oncology, Inc shares in Q4 2016, an estimated $88K.
  • Loxo Oncology, Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2304 holding.
  • BlackRock Investment Management first reported a position in Loxo Oncology, Inc in Q3 2014 and has held it in 10 quarters since.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.